Mereo BioPharma (UK) Price on June 27, 2024
| 0A9G Stock | 3.55 0.15 4.41% |
If you're considering investing in Mereo Stock, it is important to understand the factors that can impact its price. As of today, the current price of Mereo BioPharma stands at 3.55, as last reported on the 30th of November, with the highest price reaching 3.55 and the lowest price hitting 3.55 during the day. Mereo BioPharma Group has Sharpe Ratio of -0.0871, which conveys that the firm had a -0.0871% return per unit of risk over the last 3 months. Mereo BioPharma exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Mereo BioPharma's Mean Deviation of 2.96, standard deviation of 3.86, and Risk Adjusted Performance of (0.07) to check out the risk estimate we provide.
Other Stockholder Equity is likely to drop to about 128.9 M in 2024. Common Stock is likely to drop to about 1.1 M in 2024. Mereo Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Mereo |
Sharpe Ratio = -0.0871
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 0A9G |
Estimated Market Risk
| 3.86 actual daily | 34 66% of assets are more volatile |
Expected Return
| -0.34 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Mereo BioPharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mereo BioPharma by adding Mereo BioPharma to a well-diversified portfolio.
Book Value 0.469 | Enterprise Value 2.7 B | Shares Float 489.9 M | Wall Street Target Price 4.38 | Earnings Share (0.28) |
Mereo BioPharma Valuation on June 27, 2024
It is possible to determine the worth of Mereo BioPharma on a given historical date. On June 27, 2024 Mereo was worth 3.46 at the beginning of the trading date compared to the closed value of 3.49. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Mereo BioPharma stock. Still, in general, we apply an absolute valuation method to find Mereo BioPharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Mereo BioPharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Mereo BioPharma's related companies.
| Open | High | Low | Close | Volume | |
| 3.42 | 3.42 | 3.35 | 3.38 | 9,723 | |
06/27/2024 | 3.46 | 3.49 | 3.46 | 3.49 | 1,600 |
| 3.51 | 3.53 | 3.45 | 3.45 | 13,853 |
| Backtest Mereo BioPharma | | | Mereo BioPharma History | | | Mereo BioPharma Valuation | Previous | Next |
Mereo BioPharma Trading Date Momentum on June 27, 2024
| On June 28 2024 Mereo BioPharma Group was traded for 3.45 at the closing time. The highest price during the trading period was 3.53 and the lowest recorded bid was listed for 3.45 . The volume for the day was 13.9 K. This history from June 28, 2024 contributed to the next trading day price decline. The daily price change to the next closing price was 1.15% . The trading delta at closing time to the current price is 1.15% . |
Mereo BioPharma Group Fundamentals Correlations and Trends
By evaluating Mereo BioPharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Mereo BioPharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Mereo financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Mereo BioPharma Stock history
Mereo BioPharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Mereo is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Mereo BioPharma Group will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Mereo BioPharma stock prices may prove useful in developing a viable investing in Mereo BioPharma
| Last Reported | Projected for Next Year | ||
| Net Loss | -39.3 M | -41.3 M |
Mereo BioPharma Stock Technical Analysis
Mereo BioPharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Mereo BioPharma Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Mereo BioPharma Group cannot be verified against its exchange. Please verify the symbol is currently traded on London Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Mereo BioPharma November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Mereo BioPharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Mereo BioPharma shares will generate the highest return on investment. By undertsting and applying Mereo BioPharma stock market strength indicators, traders can identify Mereo BioPharma Group entry and exit signals to maximize returns
Mereo BioPharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Mereo BioPharma's price direction in advance. Along with the technical and fundamental analysis of Mereo Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Mereo to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.58) | |||
| Total Risk Alpha | (1.05) | |||
| Treynor Ratio | (0.30) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Mereo Stock Analysis
When running Mereo BioPharma's price analysis, check to measure Mereo BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mereo BioPharma is operating at the current time. Most of Mereo BioPharma's value examination focuses on studying past and present price action to predict the probability of Mereo BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mereo BioPharma's price. Additionally, you may evaluate how the addition of Mereo BioPharma to your portfolios can decrease your overall portfolio volatility.